Agree with you both. This update is heavy on jargon and light on...

Agree with you both. This update is heavy on jargon and light on meaningful content, in my mind.

There is no mention of how this partnership is financially beneficial that I can tell, except for the short line “InteliCare will market this capability as a new product stream to unlock additional revenue”. Does this mean ICR receives a cut of any smart wearable that’s upsold to clients? Or is it a non-monetary “mutual benefit” type agreement, where we endorse their product(s) for our client, and they give us access to the amalgamated patient health data?

Having the capacity to incorporate wearable/other home health tech into the InteliCare system makes sense, and allows expansion of the potential client base. Each client may have different (and evolving) needs. I would just like more transparency on the nature of this partnership.

Side note, RPM = remote patient monitoring, for anyone else wondering. Couldn’t find where they defined it, but I might’ve missed it.